当前位置:
X-MOL 学术
›
J. Cachexia Sarcopenia Muscle
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Sarcopenia Is a Prognostic Factor of Adverse Effects and Mortality in Patients With Tumour: A Systematic Review and Meta-Analysis
Journal of Cachexia, Sarcopenia and Muscle ( IF 9.4 ) Pub Date : 2024-11-11 , DOI: 10.1002/jcsm.13629 Yujie Zhang, Jingjing Zhang, Yunfan Zhan, Zhe Pan, Qiaohong Liu, Wei'an Yuan
Journal of Cachexia, Sarcopenia and Muscle ( IF 9.4 ) Pub Date : 2024-11-11 , DOI: 10.1002/jcsm.13629 Yujie Zhang, Jingjing Zhang, Yunfan Zhan, Zhe Pan, Qiaohong Liu, Wei'an Yuan
The relationship between sarcopenia and the prognosis of patients with tumours who received radio- and/or chemotherapy still needs to be determined. In this study, we aim to investigate the relationship between sarcopenia and adverse effects and mortality in patients with tumours that received radio- and/or chemotherapy, stratified by study design, tumour category, the method sarcopenia assessed, treatment options, study location and among other factors.
中文翻译:
肌肉减少症是肿瘤患者不良反应和死亡率的预后因素:系统评价和荟萃分析
肌肉减少症与接受放疗和/或化疗的肿瘤患者预后之间的关系仍有待确定。在这项研究中,我们旨在调查接受放疗和/或化疗的肿瘤患者肌肉减少症与不良反应和死亡率之间的关系,按研究设计、肿瘤类别、肌肉减少症评估方法、治疗方案、研究地点等因素进行分层。
更新日期:2024-11-11
中文翻译:
肌肉减少症是肿瘤患者不良反应和死亡率的预后因素:系统评价和荟萃分析
肌肉减少症与接受放疗和/或化疗的肿瘤患者预后之间的关系仍有待确定。在这项研究中,我们旨在调查接受放疗和/或化疗的肿瘤患者肌肉减少症与不良反应和死亡率之间的关系,按研究设计、肿瘤类别、肌肉减少症评估方法、治疗方案、研究地点等因素进行分层。